41 results on '"Marin, D."'
Search Results
2. Preclinical validation of a targeted next generation sequencing-based comprehensive chromosome screening methodology in human blastocysts
3. Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL
4. Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients
5. The first case of acute unilateral pan-ureteritis caused by BK polyomavirus in an allogeneic stem cell transplant patient
6. Spatiotemporal characterization of citrus postbloom fruit drop in Brazil and its relationship to pathogen dispersal
7. 58 Consecutive Living Liver Donors. Implementation of an Educational Service Agreement Between Fundacion Programa Metropolitano De Trasplante De Hígado at Caracas, Venezuela and The Liver Transplant Center of Columbia University at New York, USA.: Abstract# D2615
8. Vascular Anatomy in Living Donor Liver Transplantation.: Abstract# D2619
9. Living Donor Liver Transplantation. Outcome After 58 Transplants in Adult and Children in a Single Center.: Abstract# D2616
10. Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT
11. Stem-like characteristics in a subset of CD161-expressing human memory CD4+ T-cells may facilitate their survival after chemotherapy: O184
12. Donor KIR2DS2/DL2 genotype status is associated with an increased incidence of severe acute graft-versus-host disease following myeloablative haematopoeitic stem cell transplantation: O160
13. KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib
14. Staging criteria based on maximal disease stage pre-transplant predicts the outcome of allogeneic stem cell transplantation for chronic myeloid leukaemia in the imatinib era: P1155
15. Chronic phase CML patients on tyrosine kinase inhibitors have a normal cellular immune response against influenza but an impaired IgM humoral response against pneumococcus after vaccination: implications for immunotherapy: P1153
16. Vitamin B12 deficiency associated with symptoms of frontotemporal dementia
17. Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
18. hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia
19. EVI-1 oncogene expression predicts survival in chronic phase CML patients resistant to imatinib: 45
20. KIR genotype is associated with progression free and overall survival following autologous stem cell transplantation for multiple myeloma: 38
21. Dasatinib may not suppress the GVL effect of donor lymphocyte infusions for CML
22. Poster Board #-Session: P231-II Use of Mycophenolate Mofetil in Liver Transplant Patients.: Abstract# 1211
23. * Survey to describe the frequency of episiotomies in vaginal births in the University of Alicante General Hospital, 2003 - 2005
24. Allogeneic myeloablative haematopoietic stem cell transplantation for chronic myeloid leukaemia in the imatinib era: O284
25. Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis
26. Going with the Flow: Trafficking-Dependent and -Independent Regulation of Serotonin Transport
27. Successful peripheral blood stem cell mobilization with granulocyte colony-stimulating factor in a patient with chronic myeloid leukemia achieving a complete cytogenetic remission with dasatinib after failing imatinib
28. A new rapid and sensitive assay for detecting the T315I BCR-ABL kinase domain mutation in chronic myeloid leukaemia
29. Interactions between integrin αIIbβ3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans
30. A retrospective analysis of sexual function, fertility and endocrine status in male long-term survivors of allografts for haematological malignancy
31. Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy
32. Total CD34+ cells per 10 HPF in bone marrow trephines of patients with chronic myeloid leukaemia correlates with probability of complete cytogenetic response following imatinib treatment
33. LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre
34. The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib
35. Percentage of CD34+ cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count
36. Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse
37. Cardiovascular risk factors in long-term survivors of allogeneic SCT for CML
38. Variable significance of low levels of Bcr-Abl transcripts in the peripheral blood after allogeneic stem cell transplant for chronic myeloid leukaemia in chronic phase
39. Computed tomography colonography: colon examination or Pandora’s box
40. Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa
41. Apolipoprotein E genotype and cognition in the very old
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.